| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Anıl Alp, Melike Karaçam Doğan, Elçin Özçelik Eroğlu, Mevhibe İrem Yildiz, Şeref Can Gürel, Suzan Öze. Transient Fever Response After ECT in a Patient with Catatonic Schizophrenia: A Case Report. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 35. issue 1. 2024-04-01. PMID:38556940. |
fever; in addition to general medical conditions such as infection, malignancy, connective tissue diseases, drug treatments, malignant hyperthermia, convulsions, it can also occur due to conditions such as neuroleptic malignant syndrome (nms), serotonin syndrome, catatonia, malignant catatonia, which are frequently encountered in psychiatry clinics. |
2024-04-01 |
2024-04-03 |
Not clear |
| Jordan Virolle, Maximilien Redon, François Montastruc, Simon Taïb, Alexis Revet, Vuk Zivkovic, Julien Da Costa, Etienne Ver. What clinical analysis of antipsychotic-induced catatonia and neuroleptic malignant syndrome tells us about the links between these two syndromes: A systematic review. Schizophrenia research. 2023-08-20. PMID:37599139. |
antipsychotic-induced catatonia (aic) and neuroleptic malignant syndrome (nms) are life-threatening adverse reactions to antipsychotic medication. |
2023-08-20 |
2023-09-07 |
Not clear |
| Scott R Beach, James Luccarelli, Nathan Praschan, Mark Fusunyan, Gregory L Fricchion. Molecular and immunological origins of catatonia. Schizophrenia research. 2023-03-25. PMID:36966063. |
furthermore, there are syndromes that overlap with catatonia that some would consider variants, including neuroleptic malignant syndrome (nms) and akinetic mutism, which may also have neuroinflammatory underpinnings. |
2023-03-25 |
2023-08-14 |
Not clear |
| Mohammad Abu-Abaa, Dhay Bahadli, Osamah Abdulhussein, Ali Abdulsahib, Daniel Landa. Cefepime-Induced Neurotoxicity Can Be Confused With Neuroleptic Malignant Syndrome, Catatonia and Serotonin Syndrome: A Case Report. Cureus. vol 15. issue 1. 2023-02-28. PMID:36852358. |
cefepime-induced neurotoxicity can be confused with neuroleptic malignant syndrome, catatonia and serotonin syndrome: a case report. |
2023-02-28 |
2023-08-14 |
Not clear |
| Aman Saini, Nazifa Begum, James Matti, Dory Anthony Ghanem, Laurie Fripp, Thomas A Pollak, Michael S Zandi, Anthony David, Glyn Lewis, Jonathan Roger. Clozapine as a treatment for catatonia: A systematic review. Schizophrenia research. 2022-09-18. PMID:36117082. |
full text original research articles in english where at least one patient with catatonia was treated with clozapine were included, provided catatonia did not occur solely in the context of neuroleptic malignant syndrome. |
2022-09-18 |
2023-08-14 |
Not clear |
| Zsuzsanna Belteczki, Julia Ujvari, Peter Dom. Clozapine Withdrawal-Induced Malignant Catatonia or Neuroleptic Malignant Syndrome: A Case Report and a Brief Review of the Literature. Clinical neuropharmacology. vol 44. issue 4. 2021-10-25. PMID:34132673. |
clozapine withdrawal-induced malignant catatonia or neuroleptic malignant syndrome: a case report and a brief review of the literature. |
2021-10-25 |
2023-08-13 |
Not clear |
| Zsuzsanna Belteczki, Julia Ujvari, Peter Dom. Clozapine Withdrawal-Induced Malignant Catatonia or Neuroleptic Malignant Syndrome: A Case Report and a Brief Review of the Literature. Clinical neuropharmacology. vol 44. issue 4. 2021-10-25. PMID:34132673. |
in addition, we analyze the main features of the very few published cases of clozapine withdrawal-induced catatonia and the relationship between neuroleptic malignant syndrome and the malignant subtype of catatonia. |
2021-10-25 |
2023-08-13 |
Not clear |
| Saral Desai, Tinu Hirachan, Anca Toma, Adela Gerolemo. Malignant Catatonia Versus Neuroleptic Malignant Syndrome. Cureus. vol 13. issue 6. 2021-07-27. PMID:34306883. |
the clinical presentations of neuroleptic malignant syndrome (nms) and malignant catatonia (mc) are similar, posing a diagnostic challenge. |
2021-07-27 |
2023-08-13 |
Not clear |
| Manuel Pereira Herrera, Aphrodite Marta Zimmerma. Case of refractory delirious mania responsive to lithium. BJPsych open. vol 7. issue 4. 2021-07-20. PMID:34184627. |
more often seen in patients with a history of bipolar disorder, it frequently presents with prominent catatonic features and overlaps with other diseases in the catatonic spectrum, such as neuroleptic malignant syndrome, serotonin syndrome and malignant catatonia. |
2021-07-20 |
2023-08-13 |
Not clear |
| Nadine C van der Burg, Asmar F Y Al Hadithy, Peter N van Harten, Jim van Os, P Roberto Bakke. The genetics of drug-related movement disorders (DRMD), reply to comment: Antipsychotic-induced catatonia and neuroleptic malignant syndrome: The dark side of the moon. Molecular psychiatry. 2021-07-10. PMID:34244618. |
the genetics of drug-related movement disorders (drmd), reply to comment: antipsychotic-induced catatonia and neuroleptic malignant syndrome: the dark side of the moon. |
2021-07-10 |
2023-08-13 |
Not clear |
| Diana Apetauerova, Pritika A Patel, Joseph D Burns, David P Lerne. Movement Disorder Emergencies. Neurologic clinics. vol 39. issue 2. 2021-06-22. PMID:33896535. |
inadvertent or purposeful overdose of many psychiatric medications can result in acute life-threatening movement disorders including serotonin syndrome, neuroleptic malignant syndrome, and malignant catatonia. |
2021-06-22 |
2023-08-13 |
Not clear |
| Dusan Hirjak, Alexander Sartorius, Katharina M Kubera, Robert Christian Wol. Antipsychotic-induced catatonia and neuroleptic malignant syndrome: the dark side of the moon. Molecular psychiatry. 2021-05-20. PMID:34012038. |
antipsychotic-induced catatonia and neuroleptic malignant syndrome: the dark side of the moon. |
2021-05-20 |
2023-08-13 |
Not clear |
| Karan Verma, Vivek Jayadeva, Raymond Serrano, Karthik Sivashanke. Diagnostic, Treatment, and System Challenges in the Management of Recurrent Neuroleptic Malignant Syndrome on a General Medical Service. Case reports in psychiatry. vol 2018. 2020-10-01. PMID:29992074. |
neuroleptic malignant syndrome (nms), an iatrogenic form of malignant catatonia, carries high morbidity and mortality rates especially in the context of delayed recognition and standard intervention protocol of lorazepam trial. |
2020-10-01 |
2023-08-13 |
Not clear |
| Julia Park, Josh Tan, Sylvia Krzeminski, Maryam Hazeghazam, Meghana Bandlamuri, Richard W Carlso. Malignant Catatonia Warrants Early Psychiatric-Critical Care Collaborative Management: Two Cases and Literature Review. Case reports in critical care. vol 2017. 2020-09-30. PMID:28250995. |
malignant catatonia (mc) is a life-threatening manifestation which can occur in the setting of an underlying neuropsychiatric syndrome or general medical illness and shares clinical and pathophysiological features and medical comorbidities with the neuroleptic malignant syndrome (nms). |
2020-09-30 |
2023-08-13 |
Not clear |
| Sebastian Rodriguez, Keith A Dufendach, Robert M Weinrei. Neuroleptic Malignant Syndrome or Catatonia? A Case Report. Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures). vol 6. issue 3. 2020-09-28. PMID:32864466. |
a review of the literature has shown that there are many similarities in the presentation of neuroleptic malignant syndrome (nms) and catatonia. |
2020-09-28 |
2023-08-13 |
Not clear |
| Suraj Rajan, Bonnie Kaas, Emile Moukheibe. Movement Disorders Emergencies. Seminars in neurology. vol 39. issue 1. 2019-04-15. PMID:30743298. |
here we review the clinical phenomenology, and diagnostic principles of neuroleptic malignant syndrome, malignant catatonia, serotonin syndrome, parkinsonism hyperpyrexia, acute parkinsonism, acute chorea-ballism, drug-induced dystonia, and status dystonicus. |
2019-04-15 |
2023-08-13 |
Not clear |
| Amita Ingole, Tarun Bastiampillai, Prashant Tibrewa. Clozapine withdrawal catatonia, psychosis and associated neuroleptic malignant syndrome. Asian journal of psychiatry. vol 30. 2019-03-15. PMID:28846884. |
clozapine withdrawal catatonia, psychosis and associated neuroleptic malignant syndrome. |
2019-03-15 |
2023-08-13 |
Not clear |
| E M Peter-Ros. Molecular hypotheses to explain the shared pathways and underlying pathobiological causes in catatonia and in catatonic presentations in neuropsychiatric disorders. Medical hypotheses. vol 113. 2018-10-15. PMID:29523295. |
snord115 abnormalities with varying downstream multigene involvement would account for catatonia across the life span within some subtypes of autism spectrum disorders, schizophrenia, bipolar and major depressive disorder, psychosis, genetic disorders, and in immune disorders such as anti-n-methyl-d-aspartate receptor (nmdar) antibody encephalitis as well as the susceptibility to the neuroleptic malignant syndrome (nms) if environmentally triggered. |
2018-10-15 |
2023-08-13 |
Not clear |
| G van Rooijen, M Strypet, A Maat, D S Scheepens, M S Oudijn, K E Klopper, D Deny. Early introduction of clozapine after neuroleptic malignant syndrome may prevent malignant catatonia: A case report. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 27. issue 1. 2018-09-06. PMID:27939254. |
early introduction of clozapine after neuroleptic malignant syndrome may prevent malignant catatonia: a case report. |
2018-09-06 |
2023-08-13 |
Not clear |
| Neera Ghaziuddin, Melissa Hendriks, Paresh Patel, Lee E Wachtel, Dirk M Dhossch. Neuroleptic Malignant Syndrome/Malignant Catatonia in Child Psychiatry: Literature Review and a Case Series. Journal of child and adolescent psychopharmacology. vol 27. issue 4. 2018-04-02. PMID:28398818. |
to describe the presentation of neuroleptic malignant syndrome (nms) and malignant catatonia (mc) in children and adolescents. |
2018-04-02 |
2023-08-13 |
Not clear |